{"id": "R42564", "inputs": [{"text": "the senate and the house have each passed bills whose provisions would affect a broad range of food and drug administration ( fda ) activities regarding drugs , biological products , and medical devices: s. 3187 , the food and drug administration safety and innovation act , passed on may 24 , 2012 ; and h.r .", "tokens": ["the", "senate", "and", "the", "house", "have", "each", "passed", "bills", "whose", "provisions", "would", "affect", "a", "broad", "range", "of", "food", "and", "drug", "administration", "(", "fda", ")", "activities", "regarding", "drugs", ",", "biological", "products", ",", "and", "medical", "devices", ":", "s.", "3187", ",", "the", "food", "and", "drug", "administration", "safety", "and", "innovation", "act", ",", "passed", "on", "may", "24", ",", "2012", ";", "and", "h.r", "."], "sentence_id": 1, "word_count": 58}, {"text": "5651 , the food and drug administration reform act of 2012 , passed on may 30 , 2012 .", "tokens": ["5651", ",", "the", "food", "and", "drug", "administration", "reform", "act", "of", "2012", ",", "passed", "on", "may", "30", ",", "2012", "."], "sentence_id": 2, "word_count": 19}, {"text": "the timing of these bills coincides with the october 1 , 2012 expiration of fda's authority under current law to collect fees under the prescription drug user fee amendments ( pdufa ) of 2007 and the medical device user fee amendments ( mdufa ) of 2007 .", "tokens": ["the", "timing", "of", "these", "bills", "coincides", "with", "the", "october", "1", ",", "2012", "expiration", "of", "fda", "'s", "authority", "under", "current", "law", "to", "collect", "fees", "under", "the", "prescription", "drug", "user", "fee", "amendments", "(", "pdufa", ")", "of", "2007", "and", "the", "medical", "device", "user", "fee", "amendments", "(", "mdufa", ")", "of", "2007", "."], "sentence_id": 3, "word_count": 48}, {"text": "because revenue from those fees supports over 2,000 full - time equivalent fda positions and accounts for more than half of the agency's drug and device review resources , members of congress have referred to the user fee reauthorizations as generally uncontroversial , must - pass legislation .", "tokens": ["because", "revenue", "from", "those", "fees", "supports", "over", "2,000", "full", "-", "time", "equivalent", "fda", "positions", "and", "accounts", "for", "more", "than", "half", "of", "the", "agency", "'s", "drug", "and", "device", "review", "resources", ",", "members", "of", "congress", "have", "referred", "to", "the", "user", "fee", "reauthorizations", "as", "generally", "uncontroversial", ",", "must", "-", "pass", "legislation", "."], "sentence_id": 4, "word_count": 49}, {"text": "the senate committee on health , education , labor , and pensions and the house committee on energy and commerce have , in addition to developing legislation that would reauthorize the drug and device user fees , crafted additional titles that would create new user fee authority for generic drugs and biosimilar biological products , permanently authorize programs to encourage or require studies of drugs for pediatric use , medical device regulation , drug regulation , and several areas , such as advisory committee conflict of interest , that cut across fda product areas .", "tokens": ["the", "senate", "committee", "on", "health", ",", "education", ",", "labor", ",", "and", "pensions", "and", "the", "house", "committee", "on", "energy", "and", "commerce", "have", ",", "in", "addition", "to", "developing", "legislation", "that", "would", "reauthorize", "the", "drug", "and", "device", "user", "fees", ",", "crafted", "additional", "titles", "that", "would", "create", "new", "user", "fee", "authority", "for", "generic", "drugs", "and", "biosimilar", "biological", "products", ",", "permanently", "authorize", "programs", "to", "encourage", "or", "require", "studies", "of", "drugs", "for", "pediatric", "use", ",", "medical", "device", "regulation", ",", "drug", "regulation", ",", "and", "several", "areas", ",", "such", "as", "advisory", "committee", "conflict", "of", "interest", ",", "that", "cut", "across", "fda", "product", "areas", "."], "sentence_id": 5, "word_count": 95}, {"text": "congress had also made user fee authorizing legislation in 2007 a vehicle for addressing other fda - related issues .", "tokens": ["congress", "had", "also", "made", "user", "fee", "authorizing", "legislation", "in", "2007", "a", "vehicle", "for", "addressing", "other", "fda", "-", "related", "issues", "."], "sentence_id": 6, "word_count": 20}, {"text": "this report provides a legislative analysis of the provisions in s. 3187 and h.r .", "tokens": ["this", "report", "provides", "a", "legislative", "analysis", "of", "the", "provisions", "in", "s.", "3187", "and", "h.r", "."], "sentence_id": 7, "word_count": 15}, {"text": "5651 , including brief summaries of relevant provisions in current law , mostly the federal food , drug , and cosmetic act ( ffdca ) .", "tokens": ["5651", ",", "including", "brief", "summaries", "of", "relevant", "provisions", "in", "current", "law", ",", "mostly", "the", "federal", "food", ",", "drug", ",", "and", "cosmetic", "act", "(", "ffdca", ")", "."], "sentence_id": 8, "word_count": 26}, {"text": "current law descriptions generally relate only to provisions that the bills would change ; the current law column , therefore , does not always provide a complete description of the relevant law .", "tokens": ["current", "law", "descriptions", "generally", "relate", "only", "to", "provisions", "that", "the", "bills", "would", "change", ";", "the", "current", "law", "column", ",", "therefore", ",", "does", "not", "always", "provide", "a", "complete", "description", "of", "the", "relevant", "law", "."], "sentence_id": 9, "word_count": 33}, {"text": "material is grouped by broad topics and presented in the general order of sections in the senate bill , the first to be reported out of committee .", "tokens": ["material", "is", "grouped", "by", "broad", "topics", "and", "presented", "in", "the", "general", "order", "of", "sections", "in", "the", "senate", "bill", ",", "the", "first", "to", "be", "reported", "out", "of", "committee", "."], "sentence_id": 10, "word_count": 28}, {"text": "the report begins each topic with a discussion of the overall issue to set the policy or legislative context of the bills' provisions and then uses a table to present the comparison of the bills and current law .", "tokens": ["the", "report", "begins", "each", "topic", "with", "a", "discussion", "of", "the", "overall", "issue", "to", "set", "the", "policy", "or", "legislative", "context", "of", "the", "bills", "'", "provisions", "and", "then", "uses", "a", "table", "to", "present", "the", "comparison", "of", "the", "bills", "and", "current", "law", "."], "sentence_id": 11, "word_count": 40}, {"text": "in tables 1 through 4 , which describe the legislative language for four user fee programs , the senate and house descriptions are merged in one column because of their substantive similarity ( the few differences are noted ) .", "tokens": ["in", "tables", "1", "through", "4", ",", "which", "describe", "the", "legislative", "language", "for", "four", "user", "fee", "programs", ",", "the", "senate", "and", "house", "descriptions", "are", "merged", "in", "one", "column", "because", "of", "their", "substantive", "similarity", "(", "the", "few", "differences", "are", "noted", ")", "."], "sentence_id": 12, "word_count": 40}, {"text": "tables 3 , 4 , and 11 address new provisions and do not , therefore , have current law columns .", "tokens": ["tables", "3", ",", "4", ",", "and", "11", "address", "new", "provisions", "and", "do", "not", ",", "therefore", ",", "have", "current", "law", "columns", "."], "sentence_id": 13, "word_count": 21}, {"text": "the remaining tables have three columns: current law , s. 3187 , and h.r .", "tokens": ["the", "remaining", "tables", "have", "three", "columns", ":", "current", "law", ",", "s.", "3187", ",", "and", "h.r", "."], "sentence_id": 14, "word_count": 16}, {"text": "5651 .", "tokens": ["5651", "."], "sentence_id": 15, "word_count": 2}, {"text": "in each table , the rows generally follow the order of provisions in the senate bill , with comparable house provisions , if any , described in the relevant senate rows .", "tokens": ["in", "each", "table", ",", "the", "rows", "generally", "follow", "the", "order", "of", "provisions", "in", "the", "senate", "bill", ",", "with", "comparable", "house", "provisions", ",", "if", "any", ",", "described", "in", "the", "relevant", "senate", "rows", "."], "sentence_id": 16, "word_count": 32}, {"text": "house provisions without comparable senate provisions are then presented in the order they appear in the house bill .", "tokens": ["house", "provisions", "without", "comparable", "senate", "provisions", "are", "then", "presented", "in", "the", "order", "they", "appear", "in", "the", "house", "bill", "."], "sentence_id": 17, "word_count": 19}, {"text": "the following grid lists the tables that follow in this report ; it also lists the section numbers of s. 3187 ( as passed ) and h.r .", "tokens": ["the", "following", "grid", "lists", "the", "tables", "that", "follow", "in", "this", "report", ";", "it", "also", "lists", "the", "section", "numbers", "of", "s.", "3187", "(", "as", "passed", ")", "and", "h.r", "."], "sentence_id": 18, "word_count": 28}, {"text": "5651 ( as passed ) covered in each table .", "tokens": ["5651", "(", "as", "passed", ")", "covered", "in", "each", "table", "."], "sentence_id": 19, "word_count": 10}, {"text": "this report is one in a suite of crs products that provide detailed background and analysis of fda - related issues .", "tokens": ["this", "report", "is", "one", "in", "a", "suite", "of", "crs", "products", "that", "provide", "detailed", "background", "and", "analysis", "of", "fda", "-", "related", "issues", "."], "sentence_id": 20, "word_count": 22}, {"text": "for further information on many of the issues that members and panelists raised in the committee hearings leading up to these bills ( including drug approval , development incentives , device regulation , pediatric drugs , and user fees ) , see the crs website ( the medical product regulation listings at http: / / www.crs.gov / pages / subissue.aspx ? cliid=2678 ) or contact [author name scrubbed] , specialist in drug safety and effectiveness , or one of the other authors of this report .", "tokens": ["for", "further", "information", "on", "many", "of", "the", "issues", "that", "members", "and", "panelists", "raised", "in", "the", "committee", "hearings", "leading", "up", "to", "these", "bills", "(", "including", "drug", "approval", ",", "development", "incentives", ",", "device", "regulation", ",", "pediatric", "drugs", ",", "and", "user", "fees", ")", ",", "see", "the", "crs", "website", "(", "the", "medical", "product", "regulation", "listings", "at", "http", ":", "/", "/", "www.crs.gov", "/", "pages", "/", "subissue.aspx", "?", "cliid=2678", ")", "or", "contact", "[", "author", "name", "scrubbed", "]", ",", "specialist", "in", "drug", "safety", "and", "effectiveness", ",", "or", "one", "of", "the", "other", "authors", "of", "this", "report", "."], "sentence_id": 21, "word_count": 89}, {"text": "titles i through iv of both the senate and house bills would authorize fda to collect user fees and direct the revenue to fund specified activities relating to prescription drugs , medical devices , generic drugs , and biosimilar biological products .", "tokens": ["titles", "i", "through", "iv", "of", "both", "the", "senate", "and", "house", "bills", "would", "authorize", "fda", "to", "collect", "user", "fees", "and", "direct", "the", "revenue", "to", "fund", "specified", "activities", "relating", "to", "prescription", "drugs", ",", "medical", "devices", ",", "generic", "drugs", ",", "and", "biosimilar", "biological", "products", "."], "sentence_id": 22, "word_count": 42}, {"text": "the first two are reauthorizations of current programs ; the second two would authorize new user fee programs .", "tokens": ["the", "first", "two", "are", "reauthorizations", "of", "current", "programs", ";", "the", "second", "two", "would", "authorize", "new", "user", "fee", "programs", "."], "sentence_id": 23, "word_count": 19}, {"text": "with the prescription drug user fee act in 1992 , congress authorized fda to collect user fees from the manufacturers of brand - name prescription drugs and biological products and to use the revenue for specified activities .", "tokens": ["with", "the", "prescription", "drug", "user", "fee", "act", "in", "1992", ",", "congress", "authorized", "fda", "to", "collect", "user", "fees", "from", "the", "manufacturers", "of", "brand", "-", "name", "prescription", "drugs", "and", "biological", "products", "and", "to", "use", "the", "revenue", "for", "specified", "activities", "."], "sentence_id": 24, "word_count": 38}, {"text": "pdufa became possible when fda , industry , and congress agreed on two concepts: ( 1 ) performance goals \u2014 fda would commit to performance goals it would negotiate with industry that set target completion times for various review processes ; and ( 2 ) use of fees \u2014 the revenue from prescription drug user fees would be used only for activities to support the review of human drug applications and would supplement \u2014 rather than replace \u2014 funding that congress appropriated to fda .", "tokens": ["pdufa", "became", "possible", "when", "fda", ",", "industry", ",", "and", "congress", "agreed", "on", "two", "concepts", ":", "(", "1", ")", "performance", "goals", "\u2014", "fda", "would", "commit", "to", "performance", "goals", "it", "would", "negotiate", "with", "industry", "that", "set", "target", "completion", "times", "for", "various", "review", "processes", ";", "and", "(", "2", ")", "use", "of", "fees", "\u2014", "the", "revenue", "from", "prescription", "drug", "user", "fees", "would", "be", "used", "only", "for", "activities", "to", "support", "the", "review", "of", "human", "drug", "applications", "and", "would", "supplement", "\u2014", "rather", "than", "replace", "\u2014", "funding", "that", "congress", "appropriated", "to", "fda", "."], "sentence_id": 25, "word_count": 86}, {"text": "the added resources from user fees allowed fda to increase staff to review what was then a backlog of new drug applications and to reduce application review times .", "tokens": ["the", "added", "resources", "from", "user", "fees", "allowed", "fda", "to", "increase", "staff", "to", "review", "what", "was", "then", "a", "backlog", "of", "new", "drug", "applications", "and", "to", "reduce", "application", "review", "times", "."], "sentence_id": 26, "word_count": 29}, {"text": "over the years , congress has added similar authority regarding medical devices and animal drugs .", "tokens": ["over", "the", "years", ",", "congress", "has", "added", "similar", "authority", "regarding", "medical", "devices", "and", "animal", "drugs", "."], "sentence_id": 27, "word_count": 16}, {"text": "user fees make up 35% of the fy2012 fda budget .", "tokens": ["user", "fees", "make", "up", "35", "%", "of", "the", "fy2012", "fda", "budget", "."], "sentence_id": 28, "word_count": 12}, {"text": "their contribution to fda's human drug program is larger at 51% .", "tokens": ["their", "contribution", "to", "fda", "'s", "human", "drug", "program", "is", "larger", "at", "51", "%", "."], "sentence_id": 29, "word_count": 14}, {"text": "following the precedent set by pdufa , all the user fee programs addressed in this legislation include both ( 1 ) legislation and ( 2 ) performance goals agreements developed with representatives of the regulated industry in consultation with representatives of patients and advocates , academic and science experts , and congressional committees .", "tokens": ["following", "the", "precedent", "set", "by", "pdufa", ",", "all", "the", "user", "fee", "programs", "addressed", "in", "this", "legislation", "include", "both", "(", "1", ")", "legislation", "and", "(", "2", ")", "performance", "goals", "agreements", "developed", "with", "representatives", "of", "the", "regulated", "industry", "in", "consultation", "with", "representatives", "of", "patients", "and", "advocates", ",", "academic", "and", "science", "experts", ",", "and", "congressional", "committees", "."], "sentence_id": 30, "word_count": 54}, {"text": "drug manufacturers may be reluctant to test drugs and medical devices in children because of economic , ethical , legal , and other obstacles .", "tokens": ["drug", "manufacturers", "may", "be", "reluctant", "to", "test", "drugs", "and", "medical", "devices", "in", "children", "because", "of", "economic", ",", "ethical", ",", "legal", ",", "and", "other", "obstacles", "."], "sentence_id": 31, "word_count": 25}, {"text": "market forces alone do not provide sufficient incentives to overcome these obstacles .", "tokens": ["market", "forces", "alone", "do", "not", "provide", "sufficient", "incentives", "to", "overcome", "these", "obstacles", "."], "sentence_id": 32, "word_count": 13}, {"text": "the best pharmaceuticals for children act ( bpca , p.l .", "tokens": ["the", "best", "pharmaceuticals", "for", "children", "act", "(", "bpca", ",", "p.l", "."], "sentence_id": 33, "word_count": 11}, {"text": "107-109 ) and the pediatric research equity act ( prea , p.l .", "tokens": ["107-109", ")", "and", "the", "pediatric", "research", "equity", "act", "(", "prea", ",", "p.l", "."], "sentence_id": 34, "word_count": 13}, {"text": "108-155 ) offer drug manufacturers financial and regulatory incentives to test their products for use in children .", "tokens": ["108-155", ")", "offer", "drug", "manufacturers", "financial", "and", "regulatory", "incentives", "to", "test", "their", "products", "for", "use", "in", "children", "."], "sentence_id": 35, "word_count": 18}, {"text": "the pediatric medical device safety and improvement act of 2007 ( pmdsia , p.l .", "tokens": ["the", "pediatric", "medical", "device", "safety", "and", "improvement", "act", "of", "2007", "(", "pmdsia", ",", "p.l", "."], "sentence_id": 36, "word_count": 15}, {"text": "110-85 ) creates reporting requirements for pediatric medical devices , incentives for manufacturers to create pediatric medical devices , and gives the fda the authority to require postmarket studies of approved pediatric devices to ensure their continued efficacy and safety .", "tokens": ["110-85", ")", "creates", "reporting", "requirements", "for", "pediatric", "medical", "devices", ",", "incentives", "for", "manufacturers", "to", "create", "pediatric", "medical", "devices", ",", "and", "gives", "the", "fda", "the", "authority", "to", "require", "postmarket", "studies", "of", "approved", "pediatric", "devices", "to", "ensure", "their", "continued", "efficacy", "and", "safety", "."], "sentence_id": 37, "word_count": 41}, {"text": "bpca and prea , passed by congress in 2002 and 2003 and subsequently reauthorized in 2007 , represent congress' attempt to address the need for pediatric testing .", "tokens": ["bpca", "and", "prea", ",", "passed", "by", "congress", "in", "2002", "and", "2003", "and", "subsequently", "reauthorized", "in", "2007", ",", "represent", "congress", "'", "attempt", "to", "address", "the", "need", "for", "pediatric", "testing", "."], "sentence_id": 38, "word_count": 29}, {"text": "bpca created an incentive ( extended market exclusivity ) for manufacturers to conduct studies on pediatric use , and prea created a requirement for manufacturers to test the safety and effectiveness of their products in pediatric populations .", "tokens": ["bpca", "created", "an", "incentive", "(", "extended", "market", "exclusivity", ")", "for", "manufacturers", "to", "conduct", "studies", "on", "pediatric", "use", ",", "and", "prea", "created", "a", "requirement", "for", "manufacturers", "to", "test", "the", "safety", "and", "effectiveness", "of", "their", "products", "in", "pediatric", "populations", "."], "sentence_id": 39, "word_count": 38}, {"text": "bpca sunsets on october 1 , 2012 , and current law authorizes prea only as long as bpca is in effect .", "tokens": ["bpca", "sunsets", "on", "october", "1", ",", "2012", ",", "and", "current", "law", "authorizes", "prea", "only", "as", "long", "as", "bpca", "is", "in", "effect", "."], "sentence_id": 40, "word_count": 22}, {"text": "extended marketing exclusivity may be an attractive incentive to a manufacturer with a product that is being sold under patent or other types of exclusivity protections .", "tokens": ["extended", "marketing", "exclusivity", "may", "be", "an", "attractive", "incentive", "to", "a", "manufacturer", "with", "a", "product", "that", "is", "being", "sold", "under", "patent", "or", "other", "types", "of", "exclusivity", "protections", "."], "sentence_id": 41, "word_count": 27}, {"text": "bpca also includes provisions to refer pediatric studies of off - patent products , which no longer have market exclusivity , to the national institutes of health ( nih ) , and manufacturer - declined studies of on - patent products to the foundation for the nih ( fnih ) .", "tokens": ["bpca", "also", "includes", "provisions", "to", "refer", "pediatric", "studies", "of", "off", "-", "patent", "products", ",", "which", "no", "longer", "have", "market", "exclusivity", ",", "to", "the", "national", "institutes", "of", "health", "(", "nih", ")", ",", "and", "manufacturer", "-", "declined", "studies", "of", "on", "-", "patent", "products", "to", "the", "foundation", "for", "the", "nih", "(", "fnih", ")", "."], "sentence_id": 42, "word_count": 51}, {"text": "bpca and prea studies result in information on new dosing , new indications of use , new safety information , and new data on effectiveness that inform labeling changes for pediatric dosing , warnings , and instructions on how to prepare formulations for pediatric populations .", "tokens": ["bpca", "and", "prea", "studies", "result", "in", "information", "on", "new", "dosing", ",", "new", "indications", "of", "use", ",", "new", "safety", "information", ",", "and", "new", "data", "on", "effectiveness", "that", "inform", "labeling", "changes", "for", "pediatric", "dosing", ",", "warnings", ",", "and", "instructions", "on", "how", "to", "prepare", "formulations", "for", "pediatric", "populations", "."], "sentence_id": 43, "word_count": 46}, {"text": "although bpca and prea were developed separately , they are usually discussed in tandem .", "tokens": ["although", "bpca", "and", "prea", "were", "developed", "separately", ",", "they", "are", "usually", "discussed", "in", "tandem", "."], "sentence_id": 44, "word_count": 15}, {"text": "their 2007 reauthorizations were paired in both committee hearings and legislative vehicle .", "tokens": ["their", "2007", "reauthorizations", "were", "paired", "in", "both", "committee", "hearings", "and", "legislative", "vehicle", "."], "sentence_id": 45, "word_count": 13}, {"text": "both s. 3187 and h.r .", "tokens": ["both", "s.", "3187", "and", "h.r", "."], "sentence_id": 46, "word_count": 6}, {"text": "2516 would permanently authorize bpca and prea .", "tokens": ["2516", "would", "permanently", "authorize", "bpca", "and", "prea", "."], "sentence_id": 47, "word_count": 8}, {"text": "they each would also amend or add provisions in current law .", "tokens": ["they", "each", "would", "also", "amend", "or", "add", "provisions", "in", "current", "law", "."], "sentence_id": 48, "word_count": 12}, {"text": "provisions in these bills are compared with each other and to current law in table 5 .", "tokens": ["provisions", "in", "these", "bills", "are", "compared", "with", "each", "other", "and", "to", "current", "law", "in", "table", "5", "."], "sentence_id": 49, "word_count": 17}, {"text": "medical devices include a wide range of products that are used to diagnose , treat , monitor , or prevent a disease or condition in a patient .", "tokens": ["medical", "devices", "include", "a", "wide", "range", "of", "products", "that", "are", "used", "to", "diagnose", ",", "treat", ",", "monitor", ",", "or", "prevent", "a", "disease", "or", "condition", "in", "a", "patient", "."], "sentence_id": 50, "word_count": 28}, {"text": "medical devices are broadly integrated into health care , and include simple devices , such as tongue depressors , as well as more complex devices , such as implantable hips .", "tokens": ["medical", "devices", "are", "broadly", "integrated", "into", "health", "care", ",", "and", "include", "simple", "devices", ",", "such", "as", "tongue", "depressors", ",", "as", "well", "as", "more", "complex", "devices", ",", "such", "as", "implantable", "hips", "."], "sentence_id": 51, "word_count": 31}, {"text": "the extent of fda authority to regulate whether a device may be marketed in the united states and how it is monitored afterward varies across types of devices .", "tokens": ["the", "extent", "of", "fda", "authority", "to", "regulate", "whether", "a", "device", "may", "be", "marketed", "in", "the", "united", "states", "and", "how", "it", "is", "monitored", "afterward", "varies", "across", "types", "of", "devices", "."], "sentence_id": 52, "word_count": 29}, {"text": "in order to determine the applicability of premarket requirements ( i.e. , clearance or approval before marketing ) for a given device , fda classifies the device based on the risk to the patient: ( 1 ) low - risk devices are class i ; ( 2 ) moderate - risk are class ii ; and ( 3 ) high - risk are class iii .", "tokens": ["in", "order", "to", "determine", "the", "applicability", "of", "premarket", "requirements", "(", "i.e", ".", ",", "clearance", "or", "approval", "before", "marketing", ")", "for", "a", "given", "device", ",", "fda", "classifies", "the", "device", "based", "on", "the", "risk", "to", "the", "patient", ":", "(", "1", ")", "low", "-", "risk", "devices", "are", "class", "i", ";", "(", "2", ")", "moderate", "-", "risk", "are", "class", "ii", ";", "and", "(", "3", ")", "high", "-", "risk", "are", "class", "iii", "."], "sentence_id": 53, "word_count": 68}, {"text": "low - risk medical devices ( class i ) and a very small number of moderate - risk medical devices ( class ii ) are exempt from premarket review .", "tokens": ["low", "-", "risk", "medical", "devices", "(", "class", "i", ")", "and", "a", "very", "small", "number", "of", "moderate", "-", "risk", "medical", "devices", "(", "class", "ii", ")", "are", "exempt", "from", "premarket", "review", "."], "sentence_id": 54, "word_count": 30}, {"text": "in general , for moderate - risk and high - risk medical devices , there are two pathways that manufacturers can use to bring such devices to market with fda's permission: ( 1 ) premarket approval ( pma ) and ( 2 ) premarket notification submission ( also known as a 510 ( k ) submission , after the section in the ffdca that authorized this type of notification ) .", "tokens": ["in", "general", ",", "for", "moderate", "-", "risk", "and", "high", "-", "risk", "medical", "devices", ",", "there", "are", "two", "pathways", "that", "manufacturers", "can", "use", "to", "bring", "such", "devices", "to", "market", "with", "fda", "'s", "permission", ":", "(", "1", ")", "premarket", "approval", "(", "pma", ")", "and", "(", "2", ")", "premarket", "notification", "submission", "(", "also", "known", "as", "a", "510", "(", "k", ")", "submission", ",", "after", "the", "section", "in", "the", "ffdca", "that", "authorized", "this", "type", "of", "notification", ")", "."], "sentence_id": 55, "word_count": 73}, {"text": "according to a 2009 gao report , of the more than 50,000 devices that were listed by manufacturers with fda from fy2003 through fy2007 , about 67% were exempt from premarket review ; the remainder entered the market via the 510 ( k ) process ( 31% ) , the pma process ( 1% ) or via other means , such as humanitarian use devices .", "tokens": ["according", "to", "a", "2009", "gao", "report", ",", "of", "the", "more", "than", "50,000", "devices", "that", "were", "listed", "by", "manufacturers", "with", "fda", "from", "fy2003", "through", "fy2007", ",", "about", "67", "%", "were", "exempt", "from", "premarket", "review", ";", "the", "remainder", "entered", "the", "market", "via", "the", "510", "(", "k", ")", "process", "(", "31", "%", ")", ",", "the", "pma", "process", "(", "1", "%", ")", "or", "via", "other", "means", ",", "such", "as", "humanitarian", "use", "devices", "."], "sentence_id": 56, "word_count": 69}, {"text": "once a device is on the market , fda has authority to carry out certain activities to monitor their safety and effectiveness .", "tokens": ["once", "a", "device", "is", "on", "the", "market", ",", "fda", "has", "authority", "to", "carry", "out", "certain", "activities", "to", "monitor", "their", "safety", "and", "effectiveness", "."], "sentence_id": 57, "word_count": 23}, {"text": "the extent of the agency's postmarket authority is tied to characteristics of the device .", "tokens": ["the", "extent", "of", "the", "agency", "'s", "postmarket", "authority", "is", "tied", "to", "characteristics", "of", "the", "device", "."], "sentence_id": 58, "word_count": 16}, {"text": "manufacturer requirements include areas such as labeling , postmarket surveillance , device tracking , and adverse event reporting .", "tokens": ["manufacturer", "requirements", "include", "areas", "such", "as", "labeling", ",", "postmarket", "surveillance", ",", "device", "tracking", ",", "and", "adverse", "event", "reporting", "."], "sentence_id": 59, "word_count": 19}, {"text": "provisions in the house and senate passed bills both would make modifications to various aspects of premarket and postmarket device regulation .", "tokens": ["provisions", "in", "the", "house", "and", "senate", "passed", "bills", "both", "would", "make", "modifications", "to", "various", "aspects", "of", "premarket", "and", "postmarket", "device", "regulation", "."], "sentence_id": 60, "word_count": 22}, {"text": "premarket modifications include those intended to: ( 1 ) streamline the de novo 510 ( k ) for novel devices ; ( 2 ) affect the efficiency , transparency , and data requirements of the 510 ( k ) and pma processes ; and ( 3 ) alter or make clarifications to certain types of exempt devices , for example , custom devices and humanitarian use devices .", "tokens": ["premarket", "modifications", "include", "those", "intended", "to", ":", "(", "1", ")", "streamline", "the", "de", "novo", "510", "(", "k", ")", "for", "novel", "devices", ";", "(", "2", ")", "affect", "the", "efficiency", ",", "transparency", ",", "and", "data", "requirements", "of", "the", "510", "(", "k", ")", "and", "pma", "processes", ";", "and", "(", "3", ")", "alter", "or", "make", "clarifications", "to", "certain", "types", "of", "exempt", "devices", ",", "for", "example", ",", "custom", "devices", "and", "humanitarian", "use", "devices", "."], "sentence_id": 61, "word_count": 69}, {"text": "with respect to postmarket regulation , provisions focus on expanding active postmarket surveillance ; altering requirements related to postmarket studies for devices ; and strengthening both device recall and tracking capabilities through a recall program and the unique device identifier system .", "tokens": ["with", "respect", "to", "postmarket", "regulation", ",", "provisions", "focus", "on", "expanding", "active", "postmarket", "surveillance", ";", "altering", "requirements", "related", "to", "postmarket", "studies", "for", "devices", ";", "and", "strengthening", "both", "device", "recall", "and", "tracking", "capabilities", "through", "a", "recall", "program", "and", "the", "unique", "device", "identifier", "system", "."], "sentence_id": 62, "word_count": 42}, {"text": "miscellaneous reforms include those aimed at increasing transparency of fda's approval and clearance decisions and processes for issuing industry guidance documents ; improving health information technology for the agency ; and harmonizing device regulation with fda's international counterparts .", "tokens": ["miscellaneous", "reforms", "include", "those", "aimed", "at", "increasing", "transparency", "of", "fda", "'s", "approval", "and", "clearance", "decisions", "and", "processes", "for", "issuing", "industry", "guidance", "documents", ";", "improving", "health", "information", "technology", "for", "the", "agency", ";", "and", "harmonizing", "device", "regulation", "with", "fda", "'s", "international", "counterparts", "."], "sentence_id": 63, "word_count": 41}, {"text": "medical device related provisions are presented in table 6 , in the order in which they appear in the senate bill .", "tokens": ["medical", "device", "related", "provisions", "are", "presented", "in", "table", "6", ",", "in", "the", "order", "in", "which", "they", "appear", "in", "the", "senate", "bill", "."], "sentence_id": 64, "word_count": 22}, {"text": "a key fda responsibility is to regulate the safety and effectiveness of drugs sold in the united states .", "tokens": ["a", "key", "fda", "responsibility", "is", "to", "regulate", "the", "safety", "and", "effectiveness", "of", "drugs", "sold", "in", "the", "united", "states", "."], "sentence_id": 65, "word_count": 19}, {"text": "fda divides that responsibility into two phases: preapproval ( premarket ) and postapproval ( postmarket ) .", "tokens": ["fda", "divides", "that", "responsibility", "into", "two", "phases", ":", "preapproval", "(", "premarket", ")", "and", "postapproval", "(", "postmarket", ")", "."], "sentence_id": 66, "word_count": 18}, {"text": "fda reviews manufacturers' applications to market drugs in the united states ; a drug may not be sold unless it has fda approval .", "tokens": ["fda", "reviews", "manufacturers", "'", "applications", "to", "market", "drugs", "in", "the", "united", "states", ";", "a", "drug", "may", "not", "be", "sold", "unless", "it", "has", "fda", "approval", "."], "sentence_id": 67, "word_count": 25}, {"text": "the agency continues its oversight of drug safety and effectiveness as long as the drug is on the market .", "tokens": ["the", "agency", "continues", "its", "oversight", "of", "drug", "safety", "and", "effectiveness", "as", "long", "as", "the", "drug", "is", "on", "the", "market", "."], "sentence_id": 68, "word_count": 20}, {"text": "for an overview of fda's responsibility in many of these areas , see crs report r41983 , how fda approves drugs and regulates their safety and effectiveness , by [author name scrubbed] .", "tokens": ["for", "an", "overview", "of", "fda", "'s", "responsibility", "in", "many", "of", "these", "areas", ",", "see", "crs", "report", "r41983", ",", "how", "fda", "approves", "drugs", "and", "regulates", "their", "safety", "and", "effectiveness", ",", "by", "[", "author", "name", "scrubbed", "]", "."], "sentence_id": 69, "word_count": 36}, {"text": "beginning with the food and drugs act of 1906 , congress has incrementally refined and expanded fda's responsibilities regarding drug approval and regulation .", "tokens": ["beginning", "with", "the", "food", "and", "drugs", "act", "of", "1906", ",", "congress", "has", "incrementally", "refined", "and", "expanded", "fda", "'s", "responsibilities", "regarding", "drug", "approval", "and", "regulation", "."], "sentence_id": 70, "word_count": 25}, {"text": "members of the 112 th congress have suggested that fda take additional efforts across the lifespan of its drug products .", "tokens": ["members", "of", "the", "112", "th", "congress", "have", "suggested", "that", "fda", "take", "additional", "efforts", "across", "the", "lifespan", "of", "its", "drug", "products", "."], "sentence_id": 71, "word_count": 21}, {"text": "provisions that either the senate or house have passed cluster around encouraging product development , expediting application and review processes , attending to product integrity , preventing and mitigating drug shortages , and regulating medical gases .", "tokens": ["provisions", "that", "either", "the", "senate", "or", "house", "have", "passed", "cluster", "around", "encouraging", "product", "development", ",", "expediting", "application", "and", "review", "processes", ",", "attending", "to", "product", "integrity", ",", "preventing", "and", "mitigating", "drug", "shortages", ",", "and", "regulating", "medical", "gases", "."], "sentence_id": 72, "word_count": 37}, {"text": "this report continues with each of those clusters , in the order they appear in the senate bill .", "tokens": ["this", "report", "continues", "with", "each", "of", "those", "clusters", ",", "in", "the", "order", "they", "appear", "in", "the", "senate", "bill", "."], "sentence_id": 73, "word_count": 19}, {"text": "the drug regulation section ends with a cluster of individual provisions that , although labeled miscellaneous , each target an area of congressional concern and potential fda responsibility .", "tokens": ["the", "drug", "regulation", "section", "ends", "with", "a", "cluster", "of", "individual", "provisions", "that", ",", "although", "labeled", "miscellaneous", ",", "each", "target", "an", "area", "of", "congressional", "concern", "and", "potential", "fda", "responsibility", "."], "sentence_id": 74, "word_count": 29}, {"text": "currently , the secretary is required to consider potential conflicts of interest in appointing persons to fda advisory committees .", "tokens": ["currently", ",", "the", "secretary", "is", "required", "to", "consider", "potential", "conflicts", "of", "interest", "in", "appointing", "persons", "to", "fda", "advisory", "committees", "."], "sentence_id": 75, "word_count": 20}, {"text": "the secretary must \"review the expertise of the individual and the financial disclosure report filed by the individual pursuant to the ethics in government act of 1978 \u2026 so as to reduce the likelihood that an appointed individual will later require\" one of two written waivers under the criminal financial conflict of interest statute , or a waiver under fda's conflict of interest waiver provision , in order to serve at advisory committee meetings .", "tokens": ["the", "secretary", "must", "``", "review", "the", "expertise", "of", "the", "individual", "and", "the", "financial", "disclosure", "report", "filed", "by", "the", "individual", "pursuant", "to", "the", "ethics", "in", "government", "act", "of", "1978", "\u2026", "so", "as", "to", "reduce", "the", "likelihood", "that", "an", "appointed", "individual", "will", "later", "require", "''", "one", "of", "two", "written", "waivers", "under", "the", "criminal", "financial", "conflict", "of", "interest", "statute", ",", "or", "a", "waiver", "under", "fda", "'s", "conflict", "of", "interest", "waiver", "provision", ",", "in", "order", "to", "serve", "at", "advisory", "committee", "meetings", "."], "sentence_id": 76, "word_count": 78}, {"text": "under the criminal financial conflict of interest statute , advisory committee members ( whether they are special or regular government employees ) are prohibited from participating \"personally and substantially \u2026 through decision , approval , disapproval , recommendation , the rendering of advice \u2026 or otherwise\" if they have a financial interest .", "tokens": ["under", "the", "criminal", "financial", "conflict", "of", "interest", "statute", ",", "advisory", "committee", "members", "(", "whether", "they", "are", "special", "or", "regular", "government", "employees", ")", "are", "prohibited", "from", "participating", "``", "personally", "and", "substantially", "\u2026", "through", "decision", ",", "approval", ",", "disapproval", ",", "recommendation", ",", "the", "rendering", "of", "advice", "\u2026", "or", "otherwise", "''", "if", "they", "have", "a", "financial", "interest", "."], "sentence_id": 77, "word_count": 55}, {"text": "advisory committee members are also prohibited from participating if any of the following have a financial interest: the member's spouse ; minor child ; general partner ; organization in which the member serves as an officer , director , trustee , general partner or employee ; or any person or organization with whom he is negotiating or has any arrangement concerning prospective employment .", "tokens": ["advisory", "committee", "members", "are", "also", "prohibited", "from", "participating", "if", "any", "of", "the", "following", "have", "a", "financial", "interest", ":", "the", "member", "'s", "spouse", ";", "minor", "child", ";", "general", "partner", ";", "organization", "in", "which", "the", "member", "serves", "as", "an", "officer", ",", "director", ",", "trustee", ",", "general", "partner", "or", "employee", ";", "or", "any", "person", "or", "organization", "with", "whom", "he", "is", "negotiating", "or", "has", "any", "arrangement", "concerning", "prospective", "employment", "."], "sentence_id": 78, "word_count": 66}, {"text": "however , the criminal financial conflict of interest statute has several waiver provisions .", "tokens": ["however", ",", "the", "criminal", "financial", "conflict", "of", "interest", "statute", "has", "several", "waiver", "provisions", "."], "sentence_id": 79, "word_count": 14}, {"text": "the first of two specifically referenced in ffdca sec .", "tokens": ["the", "first", "of", "two", "specifically", "referenced", "in", "ffdca", "sec", "."], "sentence_id": 80, "word_count": 10}, {"text": "712 allows for a waiver if the advisory committee member fully discloses the financial interest and the official who appoints the member makes a written determination , in advance , that the financial \"interest is not so substantial as to be deemed likely to affect the integrity of the services which the government may expect from such officer or employee. .", "tokens": ["712", "allows", "for", "a", "waiver", "if", "the", "advisory", "committee", "member", "fully", "discloses", "the", "financial", "interest", "and", "the", "official", "who", "appoints", "the", "member", "makes", "a", "written", "determination", ",", "in", "advance", ",", "that", "the", "financial", "``", "interest", "is", "not", "so", "substantial", "as", "to", "be", "deemed", "likely", "to", "affect", "the", "integrity", "of", "the", "services", "which", "the", "government", "may", "expect", "from", "such", "officer", "or", "employee", ".", "."], "sentence_id": 81, "word_count": 63}, {"text": "the second wavier allows the official responsible for the advisory committee member's appointment , after reviewing the financial disclosure report , to make a written certification \"that the need for the individual's services outweighs the potential for a conflict of interest created by the financial interest involved. .", "tokens": ["the", "second", "wavier", "allows", "the", "official", "responsible", "for", "the", "advisory", "committee", "member", "'s", "appointment", ",", "after", "reviewing", "the", "financial", "disclosure", "report", ",", "to", "make", "a", "written", "certification", "``", "that", "the", "need", "for", "the", "individual", "'s", "services", "outweighs", "the", "potential", "for", "a", "conflict", "of", "interest", "created", "by", "the", "financial", "interest", "involved", ".", "."], "sentence_id": 82, "word_count": 52}, {"text": "the ffdca has its own , additional prohibition and waiver for conflicts of interest .", "tokens": ["the", "ffdca", "has", "its", "own", ",", "additional", "prohibition", "and", "waiver", "for", "conflicts", "of", "interest", "."], "sentence_id": 83, "word_count": 15}, {"text": "under the current ffdca sec .", "tokens": ["under", "the", "current", "ffdca", "sec", "."], "sentence_id": 84, "word_count": 6}, {"text": "712 ( c ) ( 2 ) ( a ) , any member of an advisory committee would be prohibited from participating in any \"particular matter\" in an advisory committee meeting in which such member , or an immediate family member of such member , has a \"financial interest that could be affected by the advice given to the secretary with respect to such matter. .", "tokens": ["712", "(", "c", ")", "(", "2", ")", "(", "a", ")", ",", "any", "member", "of", "an", "advisory", "committee", "would", "be", "prohibited", "from", "participating", "in", "any", "``", "particular", "matter", "''", "in", "an", "advisory", "committee", "meeting", "in", "which", "such", "member", ",", "or", "an", "immediate", "family", "member", "of", "such", "member", ",", "has", "a", "``", "financial", "interest", "that", "could", "be", "affected", "by", "the", "advice", "given", "to", "the", "secretary", "with", "respect", "to", "such", "matter", ".", "."], "sentence_id": 85, "word_count": 70}, {"text": "the hhs secretary retains the right to grant a waiver to any member of such advisory panel to participate in \"a particular matter considered in a committee meeting,\" either as a voting or non - voting member of the advisory committee , when the secretary determines that \"it is necessary to afford the advisory committee essential expertise. .", "tokens": ["the", "hhs", "secretary", "retains", "the", "right", "to", "grant", "a", "waiver", "to", "any", "member", "of", "such", "advisory", "panel", "to", "participate", "in", "``", "a", "particular", "matter", "considered", "in", "a", "committee", "meeting", ",", "''", "either", "as", "a", "voting", "or", "non", "-", "voting", "member", "of", "the", "advisory", "committee", ",", "when", "the", "secretary", "determines", "that", "``", "it", "is", "necessary", "to", "afford", "the", "advisory", "committee", "essential", "expertise", ".", "."], "sentence_id": 86, "word_count": 63}, {"text": "provisions in s. 3187 and h.r .", "tokens": ["provisions", "in", "s.", "3187", "and", "h.r", "."], "sentence_id": 87, "word_count": 7}, {"text": "5651 regarding advisory committee conflicts of interest are summarized and compared with current law and with each other in table 13 .", "tokens": ["5651", "regarding", "advisory", "committee", "conflicts", "of", "interest", "are", "summarized", "and", "compared", "with", "current", "law", "and", "with", "each", "other", "in", "table", "13", "."], "sentence_id": 88, "word_count": 22}, {"text": "a number of additional provisions in the two bills are summarized and compared in table 14 .", "tokens": ["a", "number", "of", "additional", "provisions", "in", "the", "two", "bills", "are", "summarized", "and", "compared", "in", "table", "14", "."], "sentence_id": 89, "word_count": 17}, {"text": "these provisions are: reauthorization of the critical path public - private partnerships ; guidance regarding internet promotion of medical products ; electronic submission of applications ; tanning bed labeling ; global clinical trials ; regulatory science ; information technology ; reporting requirements for medical products covered by user fee agreements ; strategic integrated management plan for fda workforce ; patient participation in medical product discussions ; nanomaterials in fda - regulated products ; gao report regarding online pharmacies ; medication and device errors ; statutory pay - as - you - go statement ; communicating drug information , including to underrepresented subgroups ; report on small businesses ; whistleblower protection , u.s. public health service ; clinical trial registration ; compliance date for over - the - counter sunscreen products ; changes to the controlled substances act ( csa ) ; and prescription drug monitoring programs .", "tokens": ["these", "provisions", "are", ":", "reauthorization", "of", "the", "critical", "path", "public", "-", "private", "partnerships", ";", "guidance", "regarding", "internet", "promotion", "of", "medical", "products", ";", "electronic", "submission", "of", "applications", ";", "tanning", "bed", "labeling", ";", "global", "clinical", "trials", ";", "regulatory", "science", ";", "information", "technology", ";", "reporting", "requirements", "for", "medical", "products", "covered", "by", "user", "fee", "agreements", ";", "strategic", "integrated", "management", "plan", "for", "fda", "workforce", ";", "patient", "participation", "in", "medical", "product", "discussions", ";", "nanomaterials", "in", "fda", "-", "regulated", "products", ";", "gao", "report", "regarding", "online", "pharmacies", ";", "medication", "and", "device", "errors", ";", "statutory", "pay", "-", "as", "-", "you", "-", "go", "statement", ";", "communicating", "drug", "information", ",", "including", "to", "underrepresented", "subgroups", ";", "report", "on", "small", "businesses", ";", "whistleblower", "protection", ",", "u.s.", "public", "health", "service", ";", "clinical", "trial", "registration", ";", "compliance", "date", "for", "over", "-", "the", "-", "counter", "sunscreen", "products", ";", "changes", "to", "the", "controlled", "substances", "act", "(", "csa", ")", ";", "and", "prescription", "drug", "monitoring", "programs", "."], "sentence_id": 90, "word_count": 148}, {"text": "the senate voted 96-1 to pass s. 3187 on may 24 , 2012 .", "tokens": ["the", "senate", "voted", "96-1", "to", "pass", "s.", "3187", "on", "may", "24", ",", "2012", "."], "sentence_id": 91, "word_count": 14}, {"text": "the house voted 387-5 to pass h.r .", "tokens": ["the", "house", "voted", "387-5", "to", "pass", "h.r", "."], "sentence_id": 92, "word_count": 8}, {"text": "5651 on may 30 , 2012 .", "tokens": ["5651", "on", "may", "30", ",", "2012", "."], "sentence_id": 93, "word_count": 7}, {"text": "pdufa and mdufa sunset on october 1 , 2012 and committee bipartisan leadership has been committed to completing the reauthorizations before fda would have to initiate lay - off notification procedures that would disrupt drug and device application review and postmarket safety activities .", "tokens": ["pdufa", "and", "mdufa", "sunset", "on", "october", "1", ",", "2012", "and", "committee", "bipartisan", "leadership", "has", "been", "committed", "to", "completing", "the", "reauthorizations", "before", "fda", "would", "have", "to", "initiate", "lay", "-", "off", "notification", "procedures", "that", "would", "disrupt", "drug", "and", "device", "application", "review", "and", "postmarket", "safety", "activities", "."], "sentence_id": 94, "word_count": 44}, {"text": "fda - focused newsletters and the national media report that \"ping - pong\" negotiations , rather than a formal conference committee , are underway between house and senate staff and members to resolve the differences between the bills .", "tokens": ["fda", "-", "focused", "newsletters", "and", "the", "national", "media", "report", "that", "``", "ping", "-", "pong", "''", "negotiations", ",", "rather", "than", "a", "formal", "conference", "committee", ",", "are", "underway", "between", "house", "and", "senate", "staff", "and", "members", "to", "resolve", "the", "differences", "between", "the", "bills", "."], "sentence_id": 95, "word_count": 41}, {"text": "despite a successful bipartisan effort to build a core set of drug and device provisions that could join , but not derail , must - pass user fee provisions , there remain complex issues that members of congress will likely pursue after a final bill is passed out of s. 3187 and h.r .", "tokens": ["despite", "a", "successful", "bipartisan", "effort", "to", "build", "a", "core", "set", "of", "drug", "and", "device", "provisions", "that", "could", "join", ",", "but", "not", "derail", ",", "must", "-", "pass", "user", "fee", "provisions", ",", "there", "remain", "complex", "issues", "that", "members", "of", "congress", "will", "likely", "pursue", "after", "a", "final", "bill", "is", "passed", "out", "of", "s.", "3187", "and", "h.r", "."], "sentence_id": 96, "word_count": 54}, {"text": "5651 .", "tokens": ["5651", "."], "sentence_id": 97, "word_count": 2}, {"text": "these include changing the premarket approval and clearance procedures for medical devices , further developing a supply chain system that meets global demands , and looking at whether federal health program drug payment policies influence drug shortages .", "tokens": ["these", "include", "changing", "the", "premarket", "approval", "and", "clearance", "procedures", "for", "medical", "devices", ",", "further", "developing", "a", "supply", "chain", "system", "that", "meets", "global", "demands", ",", "and", "looking", "at", "whether", "federal", "health", "program", "drug", "payment", "policies", "influence", "drug", "shortages", "."], "sentence_id": 98, "word_count": 38}, {"text": "whether congress needs a must - pass vehicle , next facing fda in 2017 , to achieve these legislative changes remains to be seen .", "tokens": ["whether", "congress", "needs", "a", "must", "-", "pass", "vehicle", ",", "next", "facing", "fda", "in", "2017", ",", "to", "achieve", "these", "legislative", "changes", "remains", "to", "be", "seen", "."], "sentence_id": 99, "word_count": 25}], "section_names": ["", "introduction", "user fee acts", "pediatric medical products13", "human medical device regulation16", "human drug regulation", "advisory committees41", "administrative reforms and miscellaneous topics52", "next steps", "appendix. acronyms"], "section_lengths": [0, 21, 9, 19, 15, 10, 14, 2, 9, 0]}